S216: CLINICAL ACTIVITY OF CC-99282, A CEREBLON E3 LIGASE MODULATOR (CELMOD) AGENT, IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY NON-HODGKIN LYMPHOMA (R/R NHL) – RESULTS FROM A PHASE 1, OPEN-LABEL STUDY

Bibliographic Details
Main Authors:	J.-M. Michot, J. C. Chavez, C Carpio, S. Ferrari, T. A. Feldman, D. Morillo, J. Kuruvilla, A. Pinto, V. Ribrag, E Bachy, T. J. Buchholz, S. Carrancio, W.-C. Chou, C. Guarinos, F. Wu, S. Li, P. Patah, M. Pourdehnad, L. Nastoupil
Format:	Article
Language:	English
Published:	Wiley 2022-06-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000843756.99251.20

Internet